by Elizabeth Csaszar | Mar 27, 2017
Research and development (R&D) of a medical therapeutic is a long slog. This isn’t news to anyone working in the field. The average time to bring a new drug product to market is over a decade. Moreover, this is the timeline when everything progresses well –...
by Stacey Johnson | Feb 10, 2017
There is a trend in the regenerative medicine field to include gene therapies when describing the work being performed by academics and industry, as in “cell and gene therapies.” The wider definition better reflects how the industry is evolving and acknowledges the...
by Stacey Johnson | Jan 20, 2017
A special thing happened this week at Phacilitate’s Cell and Gene Therapy World: W.O.M.E.N. in Advanced Therapies launched. The virtual group is the result of conversations begun more than a year ago with like-minded individuals who want to give women the tools they...
by Camila Londono | Jan 11, 2017
Brain drain was a real problem for Canada in the late ‘90s. A study by Statistics Canada found that twice as many post-secondary professors and teachers went to the United States than came to Canada in that period. This untenable situation—in which education and...
by Nicole Kuchinsky | Dec 21, 2016
On November 28 local and international leaders of the regenerative medicine (RM) community gathered at the MaRS Centre in Toronto for the first ever Medicine by Design (MbD) Symposium. The event marked the first year of the MbD program at the University of Toronto (U...
Comments